LCCN Stock Overview
Operates a cannabis testing laboratory in Washington, the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
LeapCharger Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.006 |
| 52 Week High | US$2.28 |
| 52 Week Low | US$0.0006 |
| Beta | 4.05 |
| 11 Month Change | 200.00% |
| 3 Month Change | -76.00% |
| 1 Year Change | n/a |
| 33 Year Change | -99.99% |
| 5 Year Change | -99.98% |
| Change since IPO | -99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| LCCN | US Professional Services | US Market | |
|---|---|---|---|
| 7D | 39.5% | -0.2% | 0.9% |
| 1Y | n/a | 17.7% | 32.4% |
Return vs Industry: Insufficient data to determine how LCCN performed against the US Professional Services industry.
Return vs Market: Insufficient data to determine how LCCN performed against the US Market.
Price Volatility
| LCCN volatility | |
|---|---|
| LCCN Average Weekly Movement | 53.6% |
| Professional Services Industry Average Movement | 5.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: LCCN's share price has been volatile over the past 3 months.
Volatility Over Time: LCCN's weekly volatility has decreased from 431% to 54% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Praveenkumar Vijayakumar | www.leapcharger.com |
LeapCharger Corporation operates a cannabis testing laboratory in Washington, the United States. It tests cannabis and cannabis related products for growers and processors. The company was formerly known as GreenPlex Services, Inc. and changed its name to LeapCharger Corporation in May 2023.
LeapCharger Corporation Fundamentals Summary
| LCCN fundamental statistics | |
|---|---|
| Market cap | US$121.20k |
| Earnings (TTM) | -US$101.51m |
| Revenue (TTM) | US$80.93k |
2.0x
P/S Ratio0.0x
P/E RatioIs LCCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LCCN income statement (TTM) | |
|---|---|
| Revenue | US$80.93k |
| Cost of Revenue | US$71.69k |
| Gross Profit | US$9.24k |
| Other Expenses | US$101.52m |
| Earnings | -US$101.51m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.77 |
| Gross Margin | 11.41% |
| Net Profit Margin | -125,432.91% |
| Debt/Equity Ratio | -65.5% |
How did LCCN perform over the long term?
See historical performance and comparison